Wearable device study for atrial fibrillation monitoring
Part of Heart & circulation clinical trials.
This trial uses a smartphone and smartwatch to track your atrial fibrillation over time. It aims to understand how the condition progresses and the risk of blood clots.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with atrial fibrillation (any type)
- You own a smartphone and a smartwatch and can use them
- You are willing to provide electronic informed consent
- You do not have a pacemaker or similar implanted heart device
- You are not currently pregnant, breastfeeding, or planning pregnancy during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a smartwatch can accurately measure how often atrial fibrillation (irregular heartbeat) occurs. If you have AFib and can wear a watch, you may help doctors find a simpler way to track your condition.
This study tests whether using a smart watch to track your heart rhythm and guide treatment decisions can help manage paroxysmal atrial fibrillation (an irregular heartbeat that comes and goes). Researchers will monitor your heart activity continuously through wearable devices to see if this approach improves outcomes.
This trial tests if a smartwatch can accurately measure atrial fibrillation after a common heart procedure called catheter ablation. If you've had this procedure, you might be able to join and help researchers see if the smartwatch works as well as standard monitors.
This trial tests if smartphones and their accessories can detect a specific type of irregular heart rhythm called atrial fibrillation. If you have a form of atrial fibrillation or a normal heart rhythm, you may help see how well these devices work.
This trial studies whether sending heart rhythm recordings from a phone (using the KardiaMobile ECG device) can improve health care use and patient experience for people with atrial fibrillation. It may help your care team monitor you more smoothly—if you meet the study requirements.
This study tests a mobile education program for people with atrial fibrillation. If you have an Android smartphone and meet the other criteria, you may be able to join and learn how to manage your condition better.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.